- Home
- Programs and Groups
- Shared Resources
- Faculty
- Clinical Trials
- Tumor Registry
- Education
- About DCI
Quick Links
Breadcrumbs Navigation
Home > Clinical Trials > Adult Clinical Trials - Duke Cancer Care Research ProgramAdult Clinical Trials - Duke Cancer Care Research Program
If you would like to inquire about these trials, please contact Jennifer Stewart at 919-668-4907 or Cheryl Brewer at 919-668-8776.
Items 1 - 8 of 8
Items 1 - 8 of 8
Clinical trials data collection during patient care using a novel technology solution Livescribe Pulse Smartpen & Mi-Forms data collection software - for improved bedside data capture and communication
Principal Investigator: Amy Abernethy
Phase: N/A
Phone: 919-668-4907
Principal Investigator: Amy Abernethy
Phase: N/A
Phone: 919-668-4907
Multisite randomized controlled trial of continuing vs. discontinuing
statins in palliative care patients with limited prognosis
Principal Investigator: Amy Abernethy
Phase: N/A
Phone: 919-684-0257
Principal Investigator: Amy Abernethy
Phase: N/A
Phone: 919-684-0257
Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE): Usability Testing
Principal Investigator: Amy Abernethy
Phase: N/A
Phone: 919-668-4907
Principal Investigator: Amy Abernethy
Phase: N/A
Phone: 919-668-4907
Usability testing of the Q-DACT V2.0: an electronic quality monitoring system for community-based palliative care.
Principal Investigator: Amy Abernethy
Phase: N/A
Phone: 919-668-3891
Principal Investigator: Amy Abernethy
Phase: N/A
Phone: 919-668-3891
A Single-arm, Multicenter, Proof-of-concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates
Principal Investigator: Amy Abernethy
Phase: Phase II
Phone: 919-668-4907
Principal Investigator: Amy Abernethy
Phase: Phase II
Phone: 919-668-4907
A phase III multicenter, randomized, double-blind, double-dummy, active-controlled, parallel group study of the efficacy and safety of oral netupitant administered in combination with palonosetron and dexamethasone compared to oral palonosetron and dexamethasone for the prevention of nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy.
Principal Investigator: Amy Abernethy
Phase: Phase III
Phone: 919-668-4907
Principal Investigator: Amy Abernethy
Phase: Phase III
Phone: 919-668-4907
Out-of-pocket expenses for cancer care
Principal Investigator: Syed Zafar
Phase: N/A
Phone: 919-681-2151
Principal Investigator: Syed Zafar
Phase: N/A
Phone: 919-681-2151
Patient-reported treatment preference and health-related quality of life in patients with metastatic colorectal cancer
Principal Investigator: Syed Zafar
Phase: N/A
Phone: 919-681-2151
Principal Investigator: Syed Zafar
Phase: N/A
Phone: 919-681-2151
